Compositions and methods for amplification and detection of hepatitis B virus RNA, including HBV RNA transcribed from cccDNA
US11739382B2 · kind B2 · utility
0Cited by
0References
78Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2020 |
| Grant date | Aug 29, 2023 |
| Priority date | — |
| Expiry date | Nov 21, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/112
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods for the rapid detection of the presence or absence of Hepatitis B Virus (HBV) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, competitive blocking oligonucleotides, and probes targeting HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA) and kits are provided that are designed for the detection of HBV (in particular HBV RNA, in particular, HBV RNA transcribed from cccDNA, such as pgRNA).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.